On Friday, Acadia Pharmaceuticals Inc (NASDAQ: ACAD) was 3.41% up from the session before settling in for the closing price of $16.71. A 52-week range
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) kicked off on Tuesday, down -1.87% from the previous trading day, before settling in for the closing price of $16.61.
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) kicked off on Tuesday, down -2.00% from the previous trading day, before settling in for the closing price of $16.54.
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) kicked off on Tuesday, down -4.82% from the previous trading day, before settling in for the closing price of $17.03.
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) started the day on Thursday, with a price decrease of -3.24% at $17.02, before settling in for the price of
On Monday, Acadia Pharmaceuticals Inc (NASDAQ: ACAD) opened higher 3.45% from the last session, before settling in for the closing price of $17.66. Price fluctuations
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) open the trading on Thursday, with great promise as it jumped 8.93% to $17.20, before settling in for the price
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) kicked off on Monday, down -1.28% from the previous trading day, before settling in for the closing price of $14.81.
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) kicked off on Tuesday, remained unchanged from the previous trading day, before settling in for the closing price of $14.74.
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) open the trading on Wednesday, with a bit cautious approach as it glided -1.58% to $14.29, before settling in for
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
